An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: A population-based study

Susanna E. Borggreve, Hans L. Hillege, Bruce H. R. Wolffenbuttel, Paul E. de Jong, Mike W. Zuurman, Gerrit van der Steege, Arie van Tol, Robin P. F. Dullaart*, PREVEND Study Group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

116 Citations (Scopus)

Abstract

Background: Several cholesteryl ester transfer protein (CETP) polymorphisms affect high-density lipoprotein (HDL) cholesterol, but the impact of CETP gene variants on incident coronary disease in the general population is uncertain after correction for their effect on HDL cholesterol.

Design: We determined relationships between the CETP - 629C -> A promoter (n = 8141), the TaqIB (n = 8289), and the I405V (n = 8265) polymorphisms, serum lipids, C-reactive protein, and clinical factors with incident coronary heart disease (defined as death from or hospitalization for myocardial infarction, ischemic heart disease, or coronary intervention) during a median of 4.94 yr follow-up.

Subjects: A predominantly Caucasian general population was studied.

Results: HDL cholesterol was 0.08 mmol/liter higher in -629A carriers than in -629CC homozygotes (P <0.001). The unadjusted coronary hazard was 1.26 [ 95% confidence interval (CI), 0.95 - 1.68; P = 0.11] in A carriers compared with CC homozygotes and increased to 1.46 (95% CI, 1.10 - 1.95; P = 0.01) after adjustment for HDL cholesterol. This effect remained after additional adjustment for apolipoprotein A-I, triglycerides, C-reactive protein, age, and gender. Likewise, the HDL-cholesterol-adjusted hazard ratio was also higher in AA than in CC homozygotes (hazard ratio, 1.72; 95% CI, 1.22 - 2.42; P <0.01). Similar findings were obtained with the TaqIB polymorphism. The 405V allele was weakly associated with incident coronary heart disease after HDL cholesterol adjustment (P = 0.09).

Conclusions: A common CETP promoter polymorphism, which beneficially contributes to higher HDL cholesterol, is paradoxically associated with increased incidence of coronary disease in the general population. Thus, CETP gene variation may affect coronary risk apart from the level of HDL cholesterol.

Original languageEnglish
Pages (from-to)3382-3388
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume91
Issue number9
DOIs
Publication statusPublished - Sept-2006

Keywords

  • URINARY ALBUMIN EXCRETION
  • TYPE-2 DIABETES-MELLITUS
  • LIPID TRANSFER PROTEINS
  • INTIMA-MEDIA THICKNESS
  • HEART-DISEASE
  • TAQIB POLYMORPHISM
  • CETP GENE
  • ARTERY-DISEASE
  • MYOCARDIAL-INFARCTION
  • PROMOTER POLYMORPHISM

Cite this